Potential stock-shortage averted

In late January 2024, a care recipient noted a shortage of direct-acting antiviral (DAA) at his end, with three pills remaining and possibly not getting refill on time for continued treatment.

Data enumerator promptly liaised with the Provincial Health Office. It was confirmed that a stock replenishment, including 30 bottles of Elbasvir/Grazoprevir, 168 bottles of Sofosbuvir+Daclatasvir, and 217 bottles of Sofosbuvir, will be delivered to the facility (Sanglah Hospital) the following day. The care recipient collected medicines on time and treatment was not interrupted.